Mission Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.13M Sell
25,990
-2,791
-10% -$322K 0.06% 158
2025
Q4
$3.03M Buy
28,781
+1,322
+5% +$124K 0.06% 171
2025
Q3
$2.3M Sell
27,459
-2,872
-9% -$237K 0.05% 201
2025
Q2
$2.4M Sell
30,331
-2,208
-7% -$176K 0.05% 192
2025
Q1
$2.92M Sell
32,539
-213
-0.7% -$19.9K 0.07% 154
2024
Q4
$3.26M Sell
32,752
-298
-0.9% -$30.7K 0.08% 131
2024
Q3
$3.75M Buy
33,050
+43
+0.1% +$5.11K 0.09% 119
2024
Q2
$4.09M Buy
33,007
+2,977
+10% +$383K 0.11% 106
2024
Q1
$3.96M Buy
30,030
+3,173
+12% +$391K 0.1% 118
2023
Q4
$2.93M Buy
26,857
+373
+1% +$38.7K 0.1% 112
2023
Q3
$2.73M Sell
26,484
-687
-3% -$74K 0.1% 107
2023
Q2
$3.14M Buy
27,171
+547
+2% +$62.1K 0.12% 92
2023
Q1
$2.83M Buy
26,624
+33
+0.1% +$3.56K 0.12% 100
2022
Q4
$2.95M Sell
26,591
-186
-0.7% -$19K 0.14% 94
2022
Q3
$2.31M Buy
26,777
+1,588
+6% +$142K 0.12% 104
2022
Q2
$2.3M Buy
25,189
+1,080
+4% +$95.7K 0.12% 97
2022
Q1
$1.98M Buy
24,109
+160
+0.7% +$12.6K 0.09% 116
2021
Q4
$1.83M Sell
23,949
-436
-2% -$34.7K 0.08% 125
2021
Q3
$1.83M Sell
24,385
-82
-0.3% -$6.24K 0.09% 113
2021
Q2
$1.9M Buy
24,467
+580
+2% +$43.1K 0.1% 103
2021
Q1
$1.76M Buy
23,887
+1,247
+6% +$92K 0.1% 99
2020
Q4
$1.77M Buy
22,640
+598
+3% +$45.7K 0.11% 93
2020
Q3
$1.75M Buy
22,042
+669
+3% +$52.4K 0.13% 82
2020
Q2
$1.58M Buy
21,373
+3,001
+16% +$226K 0.14% 85
2020
Q1
$1.35M Sell
18,372
-279
-1% -$21.9K 0.15% 82
2019
Q4
$1.62M Buy
18,651
+349
+2% +$28.7K 0.16% 85
2019
Q3
$1.47M Sell
18,302
-1,150
-6% -$92.2K 0.16% 80
2019
Q2
$1.56M Buy
19,452
+942
+5% +$72.1K 0.17% 70
2019
Q1
$1.47M Sell
18,510
-369
-2% -$27.6K 0.17% 74
2018
Q4
$1.38M Sell
18,879
-73
-0.4% -$5.15K 0.18% 67
2018
Q3
$1.28M Sell
18,952
-3,090
-14% -$197K 0.17% 74
2018
Q2
$1.28M Sell
22,042
-3,665
-14% -$207K 0.19% 69
2018
Q1
$1.34M Sell
25,707
-481
-2% -$26K 0.22% 57
2017
Q4
$1.41M Sell
26,188
-2,550
-9% -$141K 0.24% 51
2017
Q3
$1.76M Sell
28,738
-7,274
-20% -$441K 0.32% 37
2017
Q2
$2.2M Buy
36,012
+208
+0.6% +$12.7K 0.42% 34
2017
Q1
$2.17M Sell
35,804
-9,055
-20% -$549K 0.42% 33
2016
Q4
$2.52M Sell
44,859
-9,022
-17% -$528K 0.5% 28
2016
Q3
$3.21M Buy
53,881
+5,450
+11% +$319K 0.78% 20
2016
Q2
$2.66M Sell
48,431
-126
-0.3% -$6.71K 0.71% 20
2016
Q1
$2.45M Buy
48,557
+30,961
+176% +$1.52M 0.66% 23
2015
Q4
$887K Buy
17,596
+3,366
+24% +$170K 0.25% 42
2015
Q3
$671K Sell
14,230
-1,214
-8% -$64.5K 0.2% 52
2015
Q2
$847K Buy
+15,444
New +$866K 0.29% 40

Other funds holding MRK

Mission Wealth Management's MRK Position: Q1 2026 in Review

Mission Wealth Management reduced its Merck (MRK) stake by 9.7% in Q1 2026, selling an estimated $322K and leaving 25,990 shares worth $3.13M. The position accounts for 0.06% of the portfolio, ranked #158.

Mission Wealth Management first reported a position in MRK in Q2 2015 and has held it in 44 quarters since. The position peaked at $4.09M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mission Wealth Management held 25,990 shares of Merck worth $3.13M as of Q1 2026.
  • Mission Wealth Management sold 2,791 Merck shares in Q1 2026, an estimated $322K.
  • Merck made up 0.06% of Mission Wealth Management's portfolio in Q1 2026, its #158 holding.
  • Mission Wealth Management first reported a position in Merck in Q2 2015 and has held it in 44 quarters since.
  • Mission Wealth Management's Merck position peaked at $4.09M in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mission Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.